CompaniesGenae Associates

Genae Associates

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

2

As Collaborator

3

Total Enrollment

5,585

By Phase

NA: 3

By Status

TERMINATED: 2COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT02069782
NCT02076204
Hover over trial bars to see details

Recent Trials

NCT05583591Lead Sponsor
Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma
NATerminated
58 participants
Started: Oct 1, 2022 · Completed: Apr 22, 2024
NCT02076204Collaborator
Mother and Infant Home Visiting Program Evaluation-Strong Start
NACompleted
1,059 participants
Started: Feb 28, 2014 · Completed: Jan 31, 2019
NCT01899079Collaborator
A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay
N/ACompleted
217 participants
Started: Jun 30, 2013 · Completed: Jul 31, 2014
NCT02069782Collaborator
Mother and Infant Home Visiting Program Evaluation
NAActive, not recruiting
4,232 participants
Started: Oct 31, 2012 · Completed: Sep 30, 2027
NCT01649453Lead Sponsor
A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test
N/ATerminated
19 participants
Started: May 31, 2012 · Completed: Feb 28, 2013
Related Companies
Iqvia----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired